Skip to main content

Annual Report 2024

  • $5.4B Net Income Attributed to Shareholders

    Net income attributed to shareholders is up$0.3 billion from 2023, and up $1.9 billion from 2022 transitional net income

  • $7.2B Core Earnings

    Core earnings of $7.2 billion up 8% on a constant exchange rate basis from 2023

  • $3.1B New Business Value

    New business value increased 32% compared with 2023

  • $1.60 Common Share Dividend

    Common share dividend increase of 10% from 2023

Letters to our Shareholders

Rory Gori

Letter from our CEO

Read letter
Don Lindsay

Letter from our Chair

Read letter

Raising the bar

We held our first in person Investor Day since 2017 in Hong Kong and Jakarta from June 25 to 27, 2024. Throughout the event, our leadership team shared progress against our transformation journey and announced new financial targets, including increasing our core ROE target to 18%+ by 2027, raising the cumulative remittances we expect to generate to more than $22 billion by end of 2027, and further improving our expense efficiency to <45% in the medium term.

 

25th anniversary of our IPO

To mark the 25th anniversary of our initial public offering, Manulife hosted a bell-ringing event at the Toronto Stock Exchange (TSX) and a grand closing gong ceremony at the Hong Kong Stock Exchange in October to celebrate a quarter century of growth and success.

 

President and CEO Roy Gori gives remarks at the 25th anniversary of our IPO at the TSX in 2024.

Phil Witherington, Manulife Asia CEO, speaks at the 25th anniversary of our IPO at the TSX in 2024.

abstract green and blue feather or leaf  closeup

Download Manulife's 2024 Annual Report

Download report